Project Summary:

The Administrative Core (AdminCore) will be established as an integrated, priority-setting consortium involving multiple participating institutions with collaborative programmatic involvement from NIAID with the PD to advance the science and enhance potential product outcome. The operations and management function is designed to provide administrative support that facilitates scientific collaborations and efficient use of resources. To best serve the interest of the Center, the AdminCore will be centralized at the Public Health Research Institute of New Jersey Medical School-UMDNJ. The AdminCore will be overseen by the Center PD, who will be supported by a program administrator (50% FTE) and a financial director (15% FTE) to coordinate and manage all administrative support functions. To support the Center objectives, the AdminCore will organize regular meetings of the investigators, their collaborators (and subcontractors) and Scientific Cores. In addition the AdminCore will arrange for meetings of the Executive Committee and the annual meeting of the External Scientific Advisory Committee. The AdminCore will produce and submit the annual progress report to the NIH, and will coordinate research publications, meeting presentations of study results and any logistics related to travel. The CETR Administrative Core will have the following Specific Aims:1. To establish a highly efficient operations and management structure that provides essential oversight, guidance and support services to the CETR Program Leaders and integrates a Scientific Advisory Committee and the NIAID Program representative as strategic advisors. 2. To promote the flow of information, prioritization of compound development, and resource allocations by supporting regular reviews, and to manage regulatory issues and the preparation of interim and year-end reports. 3. To establish a product development strategy that addresses logistics for intellectual property filings and licensing opportunities and negotiations. 4. To coordinate publications and presentations of results arising from these studies.


Dr. David S. Perlin, PhD is Executive Director of the Rutgers/New Jersey Medical School’s Public Health Research Institute (PHRI), a 72 year old specialized center for global infectious diseases research. He is also Director of the Rutgers Regional Biocontainment Laboratory, one of thirteen NIH-designated national centers, and a Professor of Microbiology and Molecular Genetics. Dr. Perlin helped establish PHRI as a leading tuberculosis and opportunistic infections research organization. His primary expertise is in fungal infections, mechanisms of antifungal drug resistance, and rapid diagnosis of opportunistic drug resistant bacetrial and fungal pathogens in high-risk patients. He has published more than 175 papers and book chapters and has co-authored two books. His laboratory is supported by grants from the NIH, pharma and biotech sectors. He is on the editorial board of several scientific journals and serves on the Board of Directors of the Aaron Diamond AIDS Research Center, and Scientific/Medical Advisory Boards for the CLSI, pharma and biotech companies, and PinnacleCare. He is also a member of the New York City Department of Health and Mental Hygiene Advisory Panel on Bioterrorism and Emerging Infections, the Executive Committee of the Northeast Biodefense Center, and Steering Committee for Microbiology, Immunology & Infectious Diseases of the New York Academy of Sciences.

Dr. Perlin earned an AB degree from Brandeis University in 1976 and a Ph.D. from Cornell University in 1980. He pursued postdoctoral studies at the Yale University School of Medicine and the University of Rochester School of Medicine and Dentistry. Dr. Perlin joined PHRI in 1985; he was named Scientific Director in 1992, President in 2005, and Director of the new PHRI Center in 2006. He was appointed Professor of Microbiology and Molecular Genetics in 2003 and Executive Director of PHRI and the Rutgers Regional Biocontainment Laboratory in 2010. Dr. Perlin was named a Fellow of the New York Academy of Sciences in 2005, and a Visiting Professor at the University of Manchester, UK in 2009.

Contact info:

David Perlin PhD
Executive Director and Professor
Public Health Research Institute Center
New Jersey Medical School - Rutgers, The State University of New Jersey
225 Warren Street
Newark, New Jersey 07103
Phone: (973) 854-3200
Fax: 973-854-3201

Isabela Dias Freedman, Ph.D., D.V.M.
Scientific Adm./Project Coord. CETR
PHRI/RBL – Rutgers University
225 Warren St. Newark, NJ 07103
1 (973) 972-9104 – office